• Saturday, April 19, 2025

Business

Ramaswamy’s firm sells bowel-disease drug arm for $7b

A BIOPHARMA company founded by the American presidential hopeful Vivek Ramaswamy has sold its bowel-disease drug development arm to the Swiss group Roche. Roivant Sciences will get $7.1 billion upfront…